2024-05-09 13:32:02 ET
Royalty Pharma PLC (RPRX)
Q1 2024 Earnings Conference Call
May 9, 2024 08:00 ET
Company Participants
George Grofik - Senior Vice President & Head of Investor Relations & Communications
Pablo Legorreta - Founder, Chairman & Chief Executive Officer
Marshall Urist - Executive Vice President & Head, Research & Investments
Chris Hite - Vice Chairman & Executive Vice President
Terrance Coyne - Executive Vice President & Chief Financial Officer
Conference Call Participants
Chris Shibutani - Goldman Sachs
Geoff Meacham - Bank of America
Peter Verdult - Citi
Michael DiFiore - Evercore
Steve Scala - TD Cowen
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Royalty Pharma First Quarter 2024 Earnings Conference Call.
I would like now to turn the conference over to George Grofik, Senior Vice President, Head of Investor Relations and Communications. Please go ahead, sir.
George Grofik
Good morning and good afternoon to everyone on the call. Thank you for joining us to review Royalty Pharma's first quarter 2024 results. You can find the press release with our earnings results and slides of this call on the Investors page of our website at royaltypharma.com.
Moving to Slide 3. I would like to remind you that information presented in this call contains forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from these statements. I refer you to our 10-K on file with the SEC for a description of these risks. All forward-looking statements are based on information currently available to Royalty Pharma and we assume no obligation to update any such forward-looking statements. Non-GAAP liquidity measures will be used to help you understand our financial performance. The reconciliation of these measures to our GAAP financials is provided in the earnings press release available on our website....
Read the full article on Seeking Alpha
For further details see:
Royalty Pharma PLC (RPRX) Q1 2024 Earnings Call Transcript